UncategorizedGym for the Brain introduces NeuroClimax® to enhance sessions – Longevity.Technology Empower Meds / November 12, 2025
UncategorizedAlnylam presents new data showing cardiac benefits of vutrisiran in ATTR-CM – Longevity.Technology Empower Meds / November 12, 2025
UncategorizedRona Therapeutics presents Phase 1 data for RN0361 at AHA 2025 – Longevity.Technology Empower Meds / November 12, 2025
UncategorizedDanish biotech kicks off first-in-human Alzheimer’s trial Empower Meds / November 10, 2025
UncategorizedDenali Therapeutics updates board and executive leadership ahead of commercial stage – Longevity.Technology Empower Meds / November 10, 2025
